All results
184 results for tests
-
PD GENE
Development of a central repository for PD-related genomic data for future research. The purpose of this study is to develop a central repository for…
- Ages
- 18 Years - N/A
- Sexes
- All
-
A Study of ASP1002 in Adults for Treatment of Solid Tumors
ASP1002 is a potential new treatment for people with certain solid tumors. Before ASP1002 is available as a treatment, the researchers need to understand how…
- Ages
- 18 Years - N/A
- Sexes
- All
-
1305-0023 (FIBRONEERTM ILD)
This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic Pulmonary…
- Ages
- 18 Years - N/A
- Sexes
- All
-
1305-0014 (FIBRONEERTM IPF)
This study is open to adults with a lung disease called Idiopathic Pulmonary Fibrosis (IPF). People can join the study if they are 40 years or older. If they…
- Ages
- 40 Years - N/A
- Sexes
- All
-
DISSECT-N
DISSECT-N is a post-market registry designed to assess real-world safety and effectiveness of Valiant Navion Thoracic Stent Graft System in the treatment of…
- Ages
- 18 Years - N/A
- Sexes
- All
-
BLUE-C
The primary objective of this study is to assess the sensitivity for colorectal cancer (CRC) and specificity of the mt-sDNA 2.0 test. Subjects 40 years of age…
- Ages
- 40 Years - N/A
- Sexes
- All
-
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
Spinocerebellar ataxias (SCA) are genetic neurological diseases that cause imbalance, poor coordination, and speech difficulties. There are different kinds of…
- Ages
- 6 Years - N/A
- Sexes
- All
-
PK sensitivity in fluticasone propionate dry powder inhalers
When a drug company first develops a drug, the company has to show the Food and Drug Administration (FDA) that the drug is safe and effective. If FDA concludes…
- Ages
- 18 Years - 50 Years
- Sexes
- All
-
SENSE
This study is a two-stage, pivotal, prospective, non-randomized, multi-center, within patient comparison of the SENSE device and the standard diagnostic test,…
- Ages
- 22 Years - N/A
- Sexes
- All
-
GUARDD-US
The primary aim is to determine the effect of participant and provider knowledge of a positive APOL1 status and accompanying guideline based clinical decision…
- Ages
- 18 Years - 70 Years
- Sexes
- All